GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
434

[Denied] employer carve-out was in the plan document, not the summary

Denied Long Haul ×4

employer carve-out was in the plan document, not the summary. I have gone back and forth on this for months.

Internal appeals are decided by the plan. External review is decided by an independent body and, where it applies, its determination is binding. They are separate mechanisms and the second is chronically underused.

A denial letter is required to state a reason and to reference the criterion applied. That reference is the handle: request the clinical policy document by its identifier and answer it point by point.

Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.

I will update this if the picture changes rather than quietly leaving it up.

2,832 up / 2,398 down54% upvoted19 commentsid 19qlpj21 Jul 2026

19 comments

19 in this archive, depth 3

best — the order this archive was captured in

u/kian_ferreira73 points·7 days ago·edited

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

replysharereportpermalink
u/dose_diary_danalog keeper37 points·7 days ago

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician.

Agreed — and request the bulletin by number. They have to give it to you.

replysharereportpermalink
u/tuva_kirchner46 points·7 days ago·edited

Disagree with the tone strategy. Anger has never moved a determination; matching the criterion has.

replysharereportpermalink
u/hamza_weiss-17 points·7 days ago

What has been documented as tried, and for how long?

replysharereportpermalink
u/tidy_vialdrawer_watch1 point·7 days ago

Yes — quoting their own policy bulletin back at them is far more effective than arguing in general terms.

replysharereportpermalink
u/bence_zielinski1 point·7 days ago

I would not skip the peer-to-peer. It is often the fastest route and it costs a phone call.

replysharereportpermalink
u/cardio_endpoint_c1 point·7 days ago

the diagnosis code on the claim is doing more work than anything you write

replysharereportpermalink
u/janoshik_junkieindependent tester18 points·7 days ago

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

replysharereportpermalink
u/tomas_lehtinen11 points·7 days ago

Prior authorisation criteria are republished each plan year.

Disagreeing with this line: the deadline runs from the letter date and treating it otherwise is expensive.

replysharereportpermalink
u/appeal_letter_al5 points·7 days ago·edited

a peer-to-peer call is often faster than a written appeal

replysharereportpermalink
u/formulary_fighterMOD12 points·7 days ago

Left up. It carries dates, a criterion and an outcome, which is what makes these threads useful.

replysharereportpermalink
u/milos_vestergaard4 points·7 days ago

Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.

replysharereportpermalink
u/line_bergstrom1 point·7 days ago

prior authorisation criteria change every plan year

replysharereportpermalink
u/whois_wanda8 points·6 days ago

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

replysharereportpermalink
u/hedda_aguirre3 points·6 days ago

keep every date, every reference number, every name of a department

replysharereportpermalink
u/ferran_dahlberg3 points·6 days ago

step therapy is a documentation problem, not an argument

replysharereportpermalink
u/elin_varga6 points·7 days ago

Employer-sponsored plans may be regulated differently from individually purchased ones, which changes both the appeal route and which regulator hears a complaint.

replysharereportpermalink
u/oskar_kaufmann3 points·7 days ago

Right, and keeping every date and reference number turns a frustrating process into an auditable one.

replysharereportpermalink
u/elin_varga2 points·6 days ago

ask for the denial reason in writing, always

replysharereportpermalink
About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.